Evolution of COVID-19-related olfactory disorders: A systematic review and meta-analysis

F. Orji, J. Akpeh, Nekwu E. Okolugbo, E. Chime
{"title":"Evolution of COVID-19-related olfactory disorders: A systematic review and meta-analysis","authors":"F. Orji, J. Akpeh, Nekwu E. Okolugbo, E. Chime","doi":"10.4103/ijmh.ijmh_42_22","DOIUrl":null,"url":null,"abstract":"Recently acquired olfactory dysfunction (OD) has emerged as one of the hallmark manifestations of the novel coronavirus disease (COVID-19), but the evolution of its spontaneous recovery has remained inconclusive, with reports of persistence of OD beyond 6 months of onset. We undertook this systematic review and meta-analysis with a view of generating a pooled recovery rate of COVID-19-associated ODs and attempt to examine the predictors of olfactory recovery. A systematic search of Scopus, Google Scholar, and PubMed databases, comprising all longitudinal studies reporting the trajectory of COVID-19-related OD, was carried out. The pooled recovery rate was estimated with random-effects model, and the potential heterogeneity of the subgroup sources was analyzed using a meta-regression test. After the Preferred Reporting Items for Systematic Reviews and Meta-Analysis selection process, 28 studies from 16 countries were included, with a total of 5,175 OD patients, among 11,948 COVID-19 cases. The estimated global pooled recovery rate of OD was 82.7% (95% confidence interval, 77.46–88.04%), with a pooled median duration of OD of 11.6 days. Only 2 out of 28 studies had recovery data beyond a period of 2 months. But no significant difference was found in the recovery rate regarding the length of follow-up (P = 0.840). Studies that conducted objective olfactory assessments showed a significantly higher recovery rate than those with subjective assessments (P = 0.001). Although 10 studies (36%) reported >90% recovery, 9 studies (32%) documented persistence of OD in >25% of their patients. Five out of six studies showed that hyposnia tended to show complete recovery than anosmia. Age, co-morbidities, and intranasal treatments had no effects. Test of homogeneity between subgroups using Cochran’s Q test was not significant (Q = 0.69, P = 0.40). Our meta-analysis revealed high rates of early- and medium-term recovery of COVID-19-related OD. However, it also showed disturbing rates of persistence of OD. Anosmia tended to be predictive of residual OD than hyposmia. Age, comorbidities, intranasal corticosteroid, and decongestants had no effects on OD recovery.","PeriodicalId":14106,"journal":{"name":"International Journal of Medicine and Health Development","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Medicine and Health Development","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/ijmh.ijmh_42_22","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Recently acquired olfactory dysfunction (OD) has emerged as one of the hallmark manifestations of the novel coronavirus disease (COVID-19), but the evolution of its spontaneous recovery has remained inconclusive, with reports of persistence of OD beyond 6 months of onset. We undertook this systematic review and meta-analysis with a view of generating a pooled recovery rate of COVID-19-associated ODs and attempt to examine the predictors of olfactory recovery. A systematic search of Scopus, Google Scholar, and PubMed databases, comprising all longitudinal studies reporting the trajectory of COVID-19-related OD, was carried out. The pooled recovery rate was estimated with random-effects model, and the potential heterogeneity of the subgroup sources was analyzed using a meta-regression test. After the Preferred Reporting Items for Systematic Reviews and Meta-Analysis selection process, 28 studies from 16 countries were included, with a total of 5,175 OD patients, among 11,948 COVID-19 cases. The estimated global pooled recovery rate of OD was 82.7% (95% confidence interval, 77.46–88.04%), with a pooled median duration of OD of 11.6 days. Only 2 out of 28 studies had recovery data beyond a period of 2 months. But no significant difference was found in the recovery rate regarding the length of follow-up (P = 0.840). Studies that conducted objective olfactory assessments showed a significantly higher recovery rate than those with subjective assessments (P = 0.001). Although 10 studies (36%) reported >90% recovery, 9 studies (32%) documented persistence of OD in >25% of their patients. Five out of six studies showed that hyposnia tended to show complete recovery than anosmia. Age, co-morbidities, and intranasal treatments had no effects. Test of homogeneity between subgroups using Cochran’s Q test was not significant (Q = 0.69, P = 0.40). Our meta-analysis revealed high rates of early- and medium-term recovery of COVID-19-related OD. However, it also showed disturbing rates of persistence of OD. Anosmia tended to be predictive of residual OD than hyposmia. Age, comorbidities, intranasal corticosteroid, and decongestants had no effects on OD recovery.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
covid -19相关嗅觉障碍的演变:系统综述和荟萃分析
最近获得性嗅觉功能障碍(OD)已成为新型冠状病毒病(COVID-19)的标志性表现之一,但其自发恢复的演变仍不确定,有报道称OD持续超过6个月发病。我们进行了这项系统综述和荟萃分析,以期得出与covid -19相关的ODs的综合回收率,并试图检查嗅觉恢复的预测因素。系统检索了Scopus、Google Scholar和PubMed数据库,包括报告covid -19相关OD轨迹的所有纵向研究。采用随机效应模型估计合并回收率,并采用meta回归检验分析亚组源的潜在异质性。在系统评价和荟萃分析的首选报告项目选择过程之后,来自16个国家的28项研究被纳入,在11948例COVID-19病例中,共有5175例吸毒过量患者。估计OD的总体合并回收率为82.7%(95%置信区间为77.46 ~ 88.04%),合并中位OD持续时间为11.6 d。28项研究中只有2项有超过2个月的恢复数据。两组患者的康复率随随访时间的延长无显著差异(P = 0.840)。进行客观嗅觉评估的研究显示,回收率明显高于主观评估(P = 0.001)。虽然10项研究(36%)报告了>90%的恢复,但9项研究(32%)记录了>25%的患者持续服用过量。六分之五的研究表明,睡眠不足比嗅觉缺失更容易完全恢复。年龄、合并症和鼻内治疗没有影响。Cochran’s Q检验各组间同质性差异无统计学意义(Q = 0.69, P = 0.40)。我们的荟萃分析显示,covid -19相关OD的早期和中期恢复率很高。然而,它也显示了令人不安的吸毒过量持续率。嗅觉缺失倾向于预测残留的OD而不是低氧。年龄、合并症、鼻内皮质类固醇和减充血剂对OD恢复没有影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Analysis of the incidence of polypharmacy in cases of adverse drug reactions at a Tertiary Care Centre in India Knowledge, perception, and readiness of health professionals towards the use of electronic health record during COVID-19 pandemic in Lagos, Nigeria Diet-mediated immune optimization as a preventive and therapeutic adjunct for management of multiple endocrine neoplasia Unmet need for assisted reproductive technology in Nigerian Tertiary Hospitals: An unspoken menace Factors influencing routine vaccination uptake and completion among children aged 12–23 months in Ilorin, North-Central Nigeria: A cross-sectional survey
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1